Peroxisome Proliferator Activated Receptor Delta (PPARD) Antibody

Este producto es parte de PPAR - peroxisome proliferator activated receptor
Product Graph
364€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Peroxisome Proliferator Activated Receptor Delta (PPARD) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx236665
tested applications
ELISA, WB

Description

PPARD Antibody is a Mouse Monoclonal against Peroxisome Proliferator Activated Receptor Delta (PPARD).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetPeroxisome Proliferator Activated Receptor Delta (PPARD)
HostMouse
ReactivityHuman, Mouse
Recommended DilutionWB: 1/500 - 1/1000. Optimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
ConjugationUnconjugated
IsotypeIgG1
Purity≥ 95% (SDS-PAGE)
PurificationPurified by Protein A and Protein G affinity chromatography.
Size 1100 µg
FormLiquid
Tested ApplicationsELISA, WB
BufferPBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
AvailabilityShipped within 5-12 working days.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry IceNo
UniProt IDQ03181
AliasFAAR,NUC1,NUCI,NR1C2,NUCII,PPARB,Nuclear hormone receptor 1,Nuclear receptor subfamily 1 group C member 2
BackgroundAntibody anti-PPARD
StatusRUO
NoteConcentration: 2 mg/ml - Validity: 12 months.

Descripción

Peroxisome proliferator activated receptor delta (PPARD) is another member of the peroxisome proliferator-activated receptor family that regulates the expression of genes involved in lipid metabolism, energy expenditure, and inflammation PPARD is widely expressed in tissues such as the liver, muscle, and adipose tissue, where it helps regulate fatty acid oxidation, glucose metabolism, and mitochondrial function It also plays a key role in regulating the oxidative stress response and modulating the balance between energy storage and energy expenditure PPARD activation has been linked to improvements in insulin sensitivity and lipid profile, making it a potential therapeutic target for metabolic diseases like type 2 diabetes and obesity Additionally, PPARD is involved in the regulation of inflammation and immune responses, and its dysregulation has been implicated in inflammatory diseases, atherosclerosis, and certain cancers Its role in promoting fat burning and mitochondrial function makes PPARD a promising target for the development of therapies aimed at enhancing metabolic health and combating obesity-related conditions

Related Products

EH2065

Human PPARD(Peroxisome prolifeRator-activated receptor delta) ELISA Kit

Ver Producto
FNab06664

anti- PPARD antibody

Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.

Ver Producto
FNab06665

anti- PPARD antibody

Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.

Ver Producto